Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 5, 2006, Pages 464-469

  Babu, B V ^a   Rath, K ^a   Kerketta, A S ^a   Swain, B K ^a   Mishra, S ^a   Kar, S K ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

Author keywords

Albendazole; Diethylcarbamazine; India; Lymphatic filariasis; Mass drug administration

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; DIETHYLCARBAMAZINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG ERUPTION; DRUG FATALITY; DRUG SURVEILLANCE PROGRAM; DRUG USE; FATIGUE; FEMALE; FEVER; FILARIASIS; FREQUENCY ANALYSIS; HEADACHE; HUMAN; INDIA; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MYALGIA; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PRURITUS; SCROTUM DISORDER; SEX DIFFERENCE; SOMNOLENCE; VOMITING;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DIETHYLCARBAMAZINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; FEMALE; FILARICIDES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROGRAM EVALUATION; TREATMENT OUTCOME;

EID: 33644847992     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.07.016     Document Type: Article

References (37)

1. D.G. Addiss M.J. Beach T.G. Streit S. Lutwic F.H. LeCont J.G. Lafontant A.W. Hightower P. Lammie Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children Lancet 350 1997 480-484
2. B.V. Babu S.K. Kar Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India Trop. Med. Int. Health 9 2004 702-709
3. B.V. Babu K. Satyanarayana Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India Trop. Doct. 33 2003 79-82
4. B.V. Babu A.S. Acharya G. Mallick P.K. Jangid A.N. Nayak K. Satyanarayana Lymphatic filariasis in Khurda district of Orissa, India: an epidemiological study Southeast Asian J. Trop. Med. Public Health 32 2001 240-243
5. M.J. Bockarie D.J. Tisch W. Kastens N.D.E. Alexander Z. Dimber F. Bockarie E. Ibam M.P. Alpers J.W. Kazura Mass treatment to eliminate filariasis in Papua New Guinea N. Engl. J. Med. 347 2002 1841-1848
6. G.P. Chhotray M. Mohapatra A.S. Acharya M.R. Ranjit A clinico-epidemiological perspective of lymphatic filariasis in Satyabadi block of Puri district, Orissa Indian J. Med. Res. 114 2001 65-71
7. A.P. Dash N. Mahapatra R.K. Hazra A.S. Acharya Transmission dynamics of filariasis in Khurda district of Orissa, India Southeast Asian J. Trop. Med. Public Health 29 1998 137-140
8. G. Dreyer M. Pires L. de Andrade E. Lopes Z. Medeiros J. Tenorio A. Coutinho J. Noroes J. Figueredo-Silva Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil Trans. R. Soc. Trop. Med. Hyg. 88 1994 232-236
9. S.K. Dunyo F.K. Nkumah P.E. Simonsen A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana Trans. R. Soc. Trop. Med. Hyg. 94 2000 205-211
10. J. Horton C. Witt E.A. Ottesen J.K. Lazdins D.G. Addiss K. Awadzi M.J. Beach V.Y. Belizario S.K. Dunyo M. Espinel J.O. Gyapong M. Hossain M.M. Ismail R.L. Jayakody P.J. Lammie W. Makunde D. Richard-Lenoble B. Selve R.K. Shenoy P.E. Simonsen C.N. Wamae M.V. Weerasooriya An analysis of the safety of the single dose, two drug regimen used in programmes to eliminate lymphatic filariasis Parasitology 121 Suppl. 2000 S157-S160
11. M.M. Ismail R.L. Jayakody G.J. Weil N. Nirmalan K.S. Jayasinghe W. Abeyewickrema M.H. Rezvi Sheriff H.N. Rajaratnam N. Amarasekera D.C. de Silva M.L. Michalski A.S. Dissanaike Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis Trans. R. Soc. Trop. Med. Hyg. 92 1998 94-97
12. M.M. Ismail R.L. Jayakody G.J. Weil D. Fernando M.S. De Silva G.A. De Silva W.K. Balasooriya Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis Trans. R. Soc. Trop. Med. Hyg. 95 2001 332-335
13. R.L. Jayakody C.S.S. de Silva W.M.T. Weerasinghe Treatment of Bancroftian filariasis with albendazole: Evaluation of efficacy and adverse reactions Tropical Biomedicine 10 1993 19-24
14. K. Krishnamoorthy K. Ramu A. Srividya N.C. Appavoo N.B. Saxena S. Lal P.K. Das Cost of annual mass single dose DEC distribution for the large scale control of lymphatic filariasis in Cuddalore district, India Indian J. Med. Res. 111 2000 81-89
15. N.A. Kshirsagar N.J. Gogtay B.S. Garg P.R. Deshmukh D.D. Rajgor V.S. Kadam B.G. Kirodian N.S. Ingole A.M. Mehendale L. Fleckenstein J. Karbwang J.K. Lazdins-Helds Safety, tolerability, efficacy and plasma concentration of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India Trans. R. Soc. Trop. Med. Hyg. 98 2004 205-217
16. A. Kumar S.K. Chand Prevalence of Wuchereria bancrofti infection in some coastal villages of Ganjam, Orissa J. Commun. Dis. 22 1990 209-212
17. A. Kumar A.P. Dash G.D. Mansing Prevalence of filariasis in rural Puri J. Commun. Dis. 26 1994 215-220
18. S.I. McLaughlin J. Radday M.C. Michel D.G. Addiss M.J. Beach P.J. Lammie J. Lammie R. Rheingans J. Lafontant Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000 Am. J. Trop. Med. Hyg. 68 2003 568-573
19. J. Noroes G. Dreyer A. Santos V.G. Mendes Z. Medeiros D. Addiss Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo Trans. R. Soc. Trop. Med. Hyg. 91 1997 78-81
20. E.A. Ottesen Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans Rev. Infect. Dis. 7 1985 314-356
21. E.A. Ottesen The global programme to eliminate lymphatic filariasis Trop. Med. Int. Health 5 2000 591-594
22. E.A. Ottesen V. Vijayasekaran V. Kumaraswami S.V. Perumal Pillai A. Sadanandam S. Frederick R. Prabhakar S.P. Tripathy A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis N. Engl. J. Med. 322 1990 1113-1117
23. E.A. Ottesen B.O.L. Duke M. Karam K. Behbehani Strategies and tools for the control/elimination of lymphatic filariasis Bull. World Health Organ. 75 1997 491-503
24. E.A. Ottesen M.M. Ismail J. Horton The role of albendazole in programmes to eliminate lymphatic filariasis Parasitol. Today 15 1999 382-386
25. K.D. Ramaiah P.K. Das N.C. Appavoo K. Ramu D.J. Augustin K.N. Kumar A.V. Chandrakala A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: Compliance with annual single-dose mass treatment and some related operational aspects Trop. Med. Int. Health 5 2000 842-847
26. H.P. Rang M.M. Dale J.M. Ritter Pharmacology fourth ed. 1991 Churchill Livingstone Publications London p. 743
27. R.N. Rath R.K. Das G. Mishra B.N. Mohapatra C. Ramakrishna Bancroftian filariasis in two selected rural communities in Puri district: Orissa - a comparative study of filariometric data J. Commun. Dis. 16 1984 104-112
28. R.N. Rath B.N. Mohapatra B. Das Detection of a new focus of Brugia malayi infection in Orissa J. Commun. Dis. 21 1989 39-40
29. J.H.F. Remme E.S. Alley A.P. Plaisier Estimation and prediction in tropical disease control: The example of onchocerciasis D. Mollison Epidemic Models: Their Structure and Relation to Data 1995 Cambridge University Press Cambridge 372-392
30. F.O. Richards Jr M.L. Eberhard R.T. Bryan D.F. McNeeley P.J. Lammie M.D. McNeeley Y. Bernard A.W. Hightower H.C. Spencer Comparison of high dose ivermectin and diethylcarbamazine for activity against Bancroftian filariasis in Haiti Am. J. Trop. Med. Hyg. 44 1991 3-10
31. M. Sasa Human Filariasis. A Global Survey of Epidemiology and Control 1976 University Park Press Baltimore, MD
32. R.K. Shenoy S. Dalia A. John T.K. Suma V. Kumaraswami Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations Ann. Trop. Med. Parasitol. 93 1999 643-651
33. T. Supali I.S. Ismid P. Ruckert P. Fischer Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: Adverse reactions and short-term effects on microfilariae Trop. Med. Int. Health 7 2002 894-901
34. M.J. Taylor C. Bandi A.M. Hoerauf J. Lazdins Wolbachia bacteria of filarial nematodes: A target for control? Parasitol. Today 16 2000 179-180
35. WHO Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis (in Countries where Onchocerciasis is not Co-endemic) 1999 World Health Organization Geneva
36. WHO Report on active surveillance for adverse events following the use of drug co-administration in the Global Programme to Eliminate Lymphatic Filariasis Wkly. Epidemiol. Rec. 36 2003 315-317
37. WHO Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis Wkly. Epidemiol. Rec. 79 2004 358-365